Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). [electronic resource]
Producer: 20030528Description: 597-608 p. digitalISSN:- 1120-009X
- Acute Disease
- Aged
- Anti-Infective Agents -- administration & dosage
- Aza Compounds
- Bronchitis, Chronic -- drug therapy
- Ceftriaxone -- administration & dosage
- Costs and Cost Analysis
- Female
- Fluoroquinolones
- Humans
- Italy
- Male
- Middle Aged
- Moxifloxacin
- National Health Programs -- economics
- Quinolines
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.